Correction to: Histone Deacetylase Inhibitor RGFP109 Overcomes Temozolomide Resistance by Blocking NF-κB-Dependent Transcription in Glioblastoma Cell Lines.

Li, Zong-yang; Li, Qing-zhong; Chen, Lei; Chen, Bao-dong; Wang, Bo; Zhang, Xie-jun; Li, Wei-ping; Res, Neurochem

This document is a correction notice for an article titled "Histone Deacetylase Inhibitor RGFP109 Overcomes Temozolomide Resistance by Blocking NF-κB-Dependent Transcription in Glioblastoma Cell Lines" published in the journal Neurochemical Research. The correction states that there was an error in the protein bands for Total IκBα in Fig. 4B and α-tubulin in Fig. 5C, which were interchanged. The corrected figures are provided in the notice. The correction notice also includes a publisher's note stating that Springer Nature remains neutral regarding jurisdictional claims and institutional affiliations.

HISTONE deacetylase inhibitors; CYTOTOXINS; GENETIC transcription; TEMOZOLOMIDE; HISTONES

Neurochemical Research, 2024, Vol 49, Issue 11, p3176

0364-3190

Academic Journal

10.1007/s11064-024-04237-2